These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 40314)

  • 21. [Potassium levels during treatment with Torrat].
    Seeliger S; Smolarz A; Glocke M; Timmler R
    MMW Munch Med Wochenschr; 1979 Jan; 121(3):103-6. PubMed ID: 33331
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antiglaucomatous effectiveness of beta receptor blockers with special reference to metipranolol].
    Noack E
    Klin Monbl Augenheilkd; 1986 Jul; 189(1):1-3. PubMed ID: 2876128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.
    Planz G; Haass H; Lamberts B
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):469-73. PubMed ID: 6128312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The antihypertensive effect of a new beta-blocking drug timolol in combination with hydrochlorothiazide].
    Pyörälä K; Mattila S; Leirisalo M; Toivonen S
    Duodecim; 1976; 92(11):588-96. PubMed ID: 7444
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tertatolol--characteristics of the drug].
    Tomaszewski R; Kliz J
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in risk factors (cholesterol and triglycerides) in the treatment of high blood pressure with beta blockers and thiazide diuretics ].
    Ocón J; Doñate T; Yáñez C; del Río G
    Med Clin (Barc); 1982 Jun 16-30; 79(2):70-3. PubMed ID: 6126621
    [No Abstract]   [Full Text] [Related]  

  • 29. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A; Pyöräiä K
    Duodecim; 1976; 92(11):597-603. PubMed ID: 7445
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical and metabolic effects of metipranolol].
    Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F
    Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
    Zonis BIa; Brin VB
    Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
    [No Abstract]   [Full Text] [Related]  

  • 32. Calcium antagonist and beta blocker regimens found equally effective in hypertensive patients with coronary artery disease.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jan; 15(2):1, 5-6. PubMed ID: 14994735
    [No Abstract]   [Full Text] [Related]  

  • 33. Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
    González-Gómez A; Gamio Capestany F; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1983; 25(4):233-40. PubMed ID: 6139268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of hydrochlorothiazide and hydrochlorothiazide plus bevantolol in hypertension.
    Lucas CP; Morledge JH; Tessman DK
    Clin Ther; 1985; 8(1):49-60. PubMed ID: 2870810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of crystepin and obsidan in patients with hypertension].
    Leviashvili BI
    Vrach Delo; 1986 Mar; (3):22-4. PubMed ID: 2872750
    [No Abstract]   [Full Text] [Related]  

  • 36. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
    Liou YS; Ma T; Tien L; Lin CM; Jong GP
    Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A pharmacokinetic study of korinfar-retard in monotherapy and in combination with cordanum and triampur in patients with arterial hypertension].
    Kukes VG; Ignat'ev VI; Kurapov AP; Pavlov SS; Rumiantsev AS; Chil'tsov VV
    Eksp Klin Farmakol; 1994; 57(6):50-2. PubMed ID: 7756964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dangerous antihypertensive treatment.
    Goodfellow R
    Br Med J; 1979 Sep; 2(6193):794. PubMed ID: 42466
    [No Abstract]   [Full Text] [Related]  

  • 40. Spironolactone in the treatment of hypertension: a review.
    Brest AN
    Clin Ther; 1986; 8(5):568-85. PubMed ID: 2876776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.